Seung Hak Lee1,2,3, Hae-Yoon Jung1,2, Seo Jung Yun1, Byung-Mo Oh1, Han Gil Seo1. 1. Department of Rehabilitation Medicine, Seoul National University Hospital, Seoul, Republic of Korea. 2. Department of Rehabilitation Medicine, Incheon Workers Compensation Hospital, Incheon, Republic of Korea. 3. Department of Rehabilitation Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
Abstract
BACKGROUND: Rehabilitation therapy using a virtual reality (VR) system for stroke patients has gained attention. However, few studies have investigated fully immersive VR using a head-mount display (HMD) for upper extremity rehabilitation in stroke patients. OBJECTIVE: To investigate the feasibility, preliminary efficacy, and usability of a fully immersive VR rehabilitation program using a commercially available HMD for upper-limb rehabilitation in stroke patients. DESIGN: A feasibility study. SETTING: Two rehabilitation centers. PARTICIPANTS: Twelve stroke patients with upper extremity weakness. INTERVENTIONS: Five upper extremity rehabilitation tasks were implemented in a virtual environment, and the participants wore an HMD (HTC Vive) and trained with appropriate tasks. Participants received a total of 10 sessions two to three times a week, consisting of 30 minutes per session. MAIN OUTCOME MEASURES: Both patient participation and adverse effects of VR training were monitored. Primary efficacy was assessed using functional outcomes (Action Research Arm Test, Box and Block Test, and modified Barthel Index), before and after the intervention. Usability was assessed using a self-reported questionnaire. RESULTS: Three patients discontinued VR training, and nine patients completed the entire training sessions and there were no adverse effects due to motion sickness. The patients who received all sessions showed significant functional improvement in all outcome measures after training (P < .05 for all measures). The overall satisfaction was 6.3 ± 0.8 on a 7-point Likert scale in all participants. CONCLUSIONS: A fully immersive VR rehabilitation program using an HMD for rehabilitation of the upper extremities following stroke is feasible and, in this small study, no serious adverse effects were identified. LEVEL OF EVIDENCE: IV.
BACKGROUND: Rehabilitation therapy using a virtual reality (VR) system for strokepatients has gained attention. However, few studies have investigated fully immersive VR using a head-mount display (HMD) for upper extremity rehabilitation in strokepatients. OBJECTIVE: To investigate the feasibility, preliminary efficacy, and usability of a fully immersive VR rehabilitation program using a commercially available HMD for upper-limb rehabilitation in strokepatients. DESIGN: A feasibility study. SETTING: Two rehabilitation centers. PARTICIPANTS: Twelve strokepatients with upper extremity weakness. INTERVENTIONS: Five upper extremity rehabilitation tasks were implemented in a virtual environment, and the participants wore an HMD (HTC Vive) and trained with appropriate tasks. Participants received a total of 10 sessions two to three times a week, consisting of 30 minutes per session. MAIN OUTCOME MEASURES: Both patient participation and adverse effects of VR training were monitored. Primary efficacy was assessed using functional outcomes (Action Research Arm Test, Box and Block Test, and modified Barthel Index), before and after the intervention. Usability was assessed using a self-reported questionnaire. RESULTS: Three patients discontinued VR training, and nine patients completed the entire training sessions and there were no adverse effects due to motion sickness. The patients who received all sessions showed significant functional improvement in all outcome measures after training (P < .05 for all measures). The overall satisfaction was 6.3 ± 0.8 on a 7-point Likert scale in all participants. CONCLUSIONS: A fully immersive VR rehabilitation program using an HMD for rehabilitation of the upper extremities following stroke is feasible and, in this small study, no serious adverse effects were identified. LEVEL OF EVIDENCE: IV.
Authors: Roberta Bevilacqua; Elvira Maranesi; Giovanni Renato Riccardi; Valentina Di Donna; Paolo Pelliccioni; Riccardo Luzi; Fabrizia Lattanzio; Giuseppe Pelliccioni Journal: J Clin Med Date: 2019-11-05 Impact factor: 4.241
Authors: Francesco Zanatta; Anna Giardini; Antonia Pierobon; Marco D'Addario; Patrizia Steca Journal: BMC Health Serv Res Date: 2022-04-20 Impact factor: 2.908
Authors: Gabriel J Garcia; Angel Alepuz; Guillermo Balastegui; Lluis Bernat; Jonathan Mortes; Sheila Sanchez; Esther Vera; Carlos A Jara; Vicente Morell; Jorge Pomares; Jose L Ramon; Andres Ubeda Journal: Biosensors (Basel) Date: 2022-06-29